Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
The summary for the Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01): The purpose of this funding opportunity (FOA) is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus of this FOA is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists.
Federal Grant Title: | Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-17-330 |
Type of Funding: | Grant |
CFDA Numbers: | 93.396 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | May 7th, 2020 |
Original Application Deadline: | May 7th, 2020 |
Posted Date: | July 20th, 2017 |
Creation Date: | July 20th, 2017 |
Archive Date: | June 12th, 2020 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | July 20th, 2017 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-17-330.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Opt...
- • Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allow...
- • Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Tr...
- • Advancing Cancer Control Equity Research through Transformative Solutions Coordination Cen...
- • Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial O...
- • Mouse Models of Human Cancers Consortium
- • Integrative Cancer Biology Programs
- • Memory T Lymphocytes in Cancer Immunology (R21)
- More Grants from the National Institutes of Health
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
- • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
- • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...